Physician profile
Brian Parker
NPI 1558591545
$1,335.12
in general payments reported to CMS, 2019-2025
11 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $129 · 2021: $203 · 2022: $151 · 2023: $175 · 2024: $221 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Entertainment: $85.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.09 |
| Entertainment | $85.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $460.14 | 2020-2025 | Precision7, Precision 1, Dailies |
| Coopervision INC. | $242.96 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.71 | 2019-2020 | |
| Lkc Technologies, INC. | $130.31 | 2023-2024 | |
| Optos, INC. | $94.60 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $77.41 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Optovue, INC. | $71.40 | 2019 | |
| Glaukos Corporation | $68.16 | 2021 | |
| Biotissue Holdings INC. | $23.64 | 2019 | |
| Sight Sciences, INC. | $13.50 | 2022 | |
| Visioneering Technologies, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.